These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 20679727)

  • 21. Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K.
    Liu JC; Voisin V; Wang S; Wang DY; Jones RA; Datti A; Uehling D; Al-awar R; Egan SE; Bader GD; Tsao M; Mak TW; Zacksenhaus E
    EMBO Mol Med; 2014 Dec; 6(12):1542-60. PubMed ID: 25330770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation.
    Adams JR; Xu K; Liu JC; Agamez NM; Loch AJ; Wong RG; Wang W; Wright KL; Lane TF; Zacksenhaus E; Egan SE
    Cancer Res; 2011 Apr; 71(7):2706-17. PubMed ID: 21324922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis.
    Pellegrini P; Cordero A; Gallego MI; Dougall WC; Muñoz P; Pujana MA; Gonzalez-Suarez E
    Stem Cells; 2013 Sep; 31(9):1954-65. PubMed ID: 23766243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation.
    van Miltenburg MH; van Nimwegen MJ; Tijdens I; Lalai R; Kuiper R; Klarenbeek S; Schouten PC; de Vries A; Jonkers J; van de Water B
    Br J Cancer; 2014 May; 110(11):2747-55. PubMed ID: 24809783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The gain of function of p53 cancer mutant in promoting mammary tumorigenesis.
    Lu X; Liu DP; Xu Y
    Oncogene; 2013 Jun; 32(23):2900-6. PubMed ID: 22824795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53R172H and p53R245W Hotspot Mutations Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional Mediator.
    McDaniel JM; Morrissey RL; Dibra D; Patel LR; Xiong S; Zhang Y; Chau GP; Su X; Qi Y; El-Naggar AK; Lozano G
    Cancer Res Commun; 2024 Aug; 4(8):1991-2007. PubMed ID: 38994678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors.
    Chiche A; Moumen M; Romagnoli M; Petit V; Lasla H; Jézéquel P; de la Grange P; Jonkers J; Deugnier MA; Glukhova MA; Faraldo MM
    Oncogene; 2017 Apr; 36(17):2355-2365. PubMed ID: 27775073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin cooperates with loss of p53 to promote claudin-low mammary carcinomas.
    O'Leary KA; Rugowski DE; Sullivan R; Schuler LA
    Oncogene; 2014 Jun; 33(23):3075-82. PubMed ID: 23873024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models.
    Blanco-Aparicio C; Cañamero M; Cecilia Y; Pequeño B; Renner O; Ferrer I; Carnero A
    PLoS One; 2010 Feb; 5(2):e9305. PubMed ID: 20174572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of Brca1 and Trp53 in adult mouse mammary ductal epithelium results in development of hormone receptor-positive or hormone receptor-negative tumors, depending on inactivation of Rb family proteins.
    Szabova L; Gordon MB; Lu L; Pate N; Bassel L; Iacovelli AJ; Karim B; Homan PJ; Householder DB; Guerin TM; Burkett S; Day AM; Custer W; Weaver Ohler Z
    Breast Cancer Res; 2022 Nov; 24(1):75. PubMed ID: 36333737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
    Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
    Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.
    Palaniappan M; Edwards D; Creighton CJ; Medina D; Conneely OM
    PLoS One; 2018; 13(3):e0194913. PubMed ID: 29590203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multipotent luminal mammary cancer stem cells model tumor heterogeneity.
    Bao L; Cardiff RD; Steinbach P; Messer KS; Ellies LG
    Breast Cancer Res; 2015 Oct; 17(1):137. PubMed ID: 26467658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem Cell Determinant SOX9 Promotes Lineage Plasticity and Progression in Basal-like Breast Cancer.
    Christin JR; Wang C; Chung CY; Liu Y; Dravis C; Tang W; Oktay MH; Wahl GM; Guo W
    Cell Rep; 2020 Jun; 31(10):107742. PubMed ID: 32521267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation.
    Renner O; Blanco-Aparicio C; Grassow M; Cañamero M; Leal JF; Carnero A
    Cancer Res; 2008 Dec; 68(23):9643-53. PubMed ID: 19047141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development.
    Bai F; Chan HL; Scott A; Smith MD; Fan C; Herschkowitz JI; Perou CM; Livingstone AS; Robbins DJ; Capobianco AJ; Pei XH
    Cancer Res; 2014 Nov; 74(21):6161-72. PubMed ID: 25239453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- mice.
    Yan H; Blackburn AC; McLary SC; Tao L; Roberts AL; Xavier EA; Dickinson ES; Seo JH; Arenas RB; Otis CN; Cao QJ; Lawlor RG; Osborne BA; Kittrell FS; Medina D; Jerry DJ
    Am J Pathol; 2010 Mar; 176(3):1421-32. PubMed ID: 20110418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EMT programs promote basal mammary stem cell and tumor-initiating cell stemness by inducing primary ciliogenesis and Hedgehog signaling.
    Guen VJ; Chavarria TE; Kröger C; Ye X; Weinberg RA; Lees JA
    Proc Natl Acad Sci U S A; 2017 Dec; 114(49):E10532-E10539. PubMed ID: 29158396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S100a4 upregulation in Pik3caH1047R;Trp53R270H;MMTV-Cre-driven mammary tumors promotes metastasis.
    Yuan W; Goldstein LD; Durinck S; Chen YJ; Nguyen TT; Kljavin NM; Sokol ES; Stawiski EW; Haley B; Ziai J; Modrusan Z; Seshagiri S
    Breast Cancer Res; 2019 Dec; 21(1):152. PubMed ID: 31881983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.